Treatment with Biaoxu Ganmao Granules ameliorates cyclophosphamide-induced immunosuppression in mice: Paeoniflorin-associated modulation of the TLR4/NF-κB pathway.
BXGG partially reversed CTX-associated reductions in body weight, thymus and spleen indices and partially restored serum interleukin-2, interleukin-4 (IL-4), and interferon-gamma (IFN-γ) levels, and white blood cell, lymphocyte, platelet, and reticulocyte counts.
Abstract
Objectives
Biaoxu Ganmao Granules (BXGG) is used clinically for wind-cold syndrome; however, its effects on cyclophosphamide (CTX)-induced immunosuppression and the associated pharmacological basis remain incompletely characterized.
Methods
Two mouse cohorts were used to evaluate BXGG and paeoniflorin in a CTX-induced immunosuppression model. Body weight, thymus and spleen indices, splenic histopathology, serum cytokines, and peripheral blood cell counts were assessed. Ultra-high-performance liquid chromatography-quadrupole time-of-flight tandem mass spectrometry (UHPLC-QTOF-MS/MS), network pharmacology, and molecular docking were used to characterize BXGG constituents, blood-absorbed constituents, and putative targets. Paeoniflorin was selected as a representative blood-absorbed constituent for preliminary in vivo validation, and proteins related to the toll-like receptor 4/nuclear factor kappa B (TLR4/NF-κB) pathway were examined by Western blotting.
Results
BXGG partially reversed CTX-associated reductions in body weight, thymus and spleen indices. It also partially restored serum interleukin-2 (IL-2), interleukin-4 (IL-4), and interferon-gamma (IFN-γ) levels, and white blood cell (WBC), lymphocyte (LYMPH), platelet (PLT), and reticulocyte (RET) counts. Network analysis and docking prioritized paeoniflorin as a candidate immune-regulatory constituent. Paeoniflorin improved several CTX-impaired immune-related outcomes and decreased TLR4 expression and the phosphorylated inhibitor of κB alpha/inhibitor of κB alpha (p-IκBα/IκBα) and phosphorylated NF-κB p65/NF-κB p65 (p-p65/p65) ratios in spleen tissue.
Conclusions
BXGG ameliorated several CTX-induced immunosuppressive changes in mice. Paeoniflorin, selected as a representative absorbed constituent, partially reproduced the immunoprotective phenotype and was associated with attenuation of TLR4/NF-κB activation. The contributions and potential synergy of other absorbed compounds require further investigation.
In vitro, LJFE dose-dependently activated the Keap1/Nrf2/HO-1 signalling axis and suppressed excessive NO release in LPS-challenged macrophages, and support the potential of LJFE for further development as an immune-enhancing functional food ingredient.
Mei Peng, Xiong Pan, Guanping Yao et al.· Frontiers in Pharmacology· 0 citations
Results showed that SXD attenuated RA progression and reduced inflammatory cytokine levels in rat serum and cell culture supernatants, and support the partial involvement of Pol β-associated processes in the anti-arthritic effects of SXD.
Mechanistic studies revealed that GAMG inhibited radiation-induced activation of the NF-κB signaling pathway, while suppressing the differentiation of macrophages toward the pro-inflammatory M1-like phenotype in lung tissue.
Xinyu Wang, Zongze Yao, Zhanggui Wang et al.· Ecotoxicology and Environmen...· 0 citations
Findings indicate that LDSOL ameliorates cyclophosphamide-induced immunosuppression in mice and suggest that metabolic remodeling and gut microbiota alterations may be associated with its immunomodulatory effects.
Xinyu Chen, Guozhao Li, Zhiwei Wang et al.· Microbial Pathogenesis· 0 citations
Pentoxifylline concurrently mitigates hypoperfusion-associated neuroinflammation, neuronal injury, and glucose hypometabolism via inhibition of the TLR4/MyD88/NF-κB axis, supporting PTX as a readily translatable candidate for early VCI intervention.
It is shown that CDP dose-dependently restores splenic mass, rescues white-pulp atrophy, and suppresses megakaryocytic hyperplasia, and collectively mitigates CTX-induced splenic injury primarily through coupled redox restoration and transcriptional-level immune modulation.
Baotang Zhao, Faqing Tao, Shengfang Wang et al.· Antioxidants· 0 citations